The Clinical Core provides well-characterized patients and control subjects for novel interdisciplinary research in Center-related and collaborative projects. New subjects added to the current Longitudinal Case Series will include only persons with normal aging and patients with mild cognitive impairment (MCI) or mild dementia. This will meet the needs of Center investigators and allow them to conduct cutting-edge research to understand better the clinical and neuropathological changes that distinguish the earliest stages of Alzheimer's disease (AD) from normal aging and from other neurodegenerative diseases commonly seen in the elderly. All subjects receive comprehensive examinations, including neuropsychological, laboratory and imaging studies, and are classified at a consensus conference using explicit diagnostic inclusion and exclusion criteria. Subjects identify a study partner who serves as an informant and are encouraged to name a health care advocate and give provisional consent for an autopsy to facilitate research. Annual assessments provide longitudinal clinical and neuropsychological data. The Core refers potential subjects to clinical research projects, shares data with the National Alzheimer's Coordinating Center, and collects biological samples following agreed upon protocols for multi-center projects. In close collaboration with the Education Core, the Clinical Core serves as the primary contact point with the community and assists with educational materials and activities to promote participation in clinical studies, stimulate the interest of trainees and new investigators, and disseminate research advances widely. In conjunction with the Minority Satellite Diagnostic and Treatment Center at the Ypsilanti Family Practice Center, which serves large African-American and Hispanic communities, the Clinical Core ensures a diverse research population from which to draw potential subjects. The Core also performs developmental work using its collected longitudinal data to provide Center investigators with metrics describing individual clinical transitions and rate of disease progression in enrolled participants.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Ann Arbor
United States
Zip Code
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Michaud, Tzeyu L; High, Robin; Charlton, Mary E et al. (2017) Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord 31:209-217
Monin, Joan K; Poulin, Michael J; Brown, Stephanie L et al. (2017) Spouses' daily feelings of appreciation and self-reported well-being. Health Psychol 36:1135-1139
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Cary, Brian P; Brooks, Allen F; Fawaz, Maria V et al. (2016) Synthesis and Evaluation of [(18)F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts. ACS Chem Neurosci 7:391-8
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17

Showing the most recent 10 out of 274 publications